Time New York: Fri 22 Sep 15:03 pm  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Can Enzo Biochem (ENZ) Run Higher on Strong Earnings Estimate Revisions?

Zacks

Enzo Biochem, Inc. ENZ is an integrated life science and biotechnology company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on ENZ’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that ENZ International could be a solid choice for investors.

Current Quarter Estimates for ENZ

In the past 30 days, one estimate has gone higher for Enzo Biochem while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing from a loss of 3 cents a share 30 days ago, to a loss of 2 cents a share today, a move of 33.3%.

Current Year Estimates for ENZ

Meanwhile, Enzo Biochem’s current year figures are also looking quite promising, with one estimate moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, increasing from a loss of 12 cents per share 30 days ago to a loss of 7 cents per share today, an increase of 41.7%.

Enzo Biochem, Inc. Price and Consensus

Bottom Line

The stock has also started to move higher lately, adding 7.1% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank stocks here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020. Click here for the 6 trades >>



Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.